Aug 02, 2023 / 12:00PM GMT
Operator
Good morning. My name is Jason, and I will be your conference operator today. At this time, I would like to welcome everyone to the Karyopharm Therapeutics Second Quarter 2023 Financial Results Conference Call. (Operator Instructions). Please be advised that this call is being recorded at the company's request.
I would now like to turn the call over to Elhan Webb, Senior Vice President of Investor Relations.
Elhan Webb - Karyopharm Therapeutics Inc. - SVP of IR
Thank you, operator, and thank you all for joining us on today's conference call to discuss Karyopharm's second quarter 2023 financial results and recent company progress. We issued a press release this morning detailing our financial results for the second quarter 2023. This release, along with a slide presentation that we will reference during our call today, are available on our website. For today's call, as seen on Slide 2, I'm joined by Richard, Reshma, Sohanya and Mike, who will provide an update on our results for the second quarter and recent clinical development.
Before we
Q2 2023 Karyopharm Therapeutics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot